id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0369-0033,FDA,FDA-2007-D-0369,Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,Notice,NAD-Notice of Availability of Data,2009-12-01T05:00:00Z,2009,12,2009-12-01T05:00:00Z,2010-02-02T04:59:59Z,2024-11-12T04:48:26Z,E9-28593,1,0,0900006480a60ef1
FDA-2007-D-0369-0028,FDA,FDA-2007-D-0369,Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,Notice,NAD-Notice of Availability of Data,2009-08-18T04:00:00Z,2009,8,2009-08-18T04:00:00Z,,2013-06-25T01:06:01Z,,0,0,0900006480a0bb64
FDA-2007-D-0369-0026,FDA,FDA-2007-D-0369,Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,Notice,NAD-Notice of Availability of Data,2009-06-08T04:00:00Z,2009,6,2009-06-08T04:00:00Z,2009-09-09T03:59:59Z,2009-06-08T18:59:39Z,E9-13272,0,0,09000064809c8b2b
FDA-2007-D-0369-0025,FDA,FDA-2007-D-0369,Final Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,Notice,NAD-Notice of Availability of Data,2009-06-08T04:00:00Z,2009,6,2009-06-08T04:00:00Z,,2009-06-08T18:02:17Z,E9-13261,0,0,09000064809c8aa2